- Forums
- ASX - By Stock
- MYX
- Mayne Pharma sees strong sales growth in FY 2023
Mayne Pharma sees strong sales growth in FY 2023, page-69
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.30 |
Change
0.100(1.92%) |
Mkt cap ! $454.2M |
Open | High | Low | Value | Volume |
$5.20 | $5.42 | $5.12 | $1.535M | 291.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | $5.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.37 | 760 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2805 | 5.600 |
2 | 1060 | 5.550 |
3 | 503 | 5.540 |
2 | 193 | 5.530 |
2 | 762 | 5.520 |
Price($) | Vol. | No. |
---|---|---|
4.770 | 1 | 1 |
4.980 | 5 | 1 |
5.020 | 826 | 5 |
5.030 | 699 | 8 |
5.140 | 1165 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online